Heyman Richard A.: insider trades.
Heyman Richard A. reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($161K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Heyman Richard A.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Oric Pharmaceuticals, Inc. (ORIC) | Director | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-24 | Oric Pharmaceuticals, Inc. | M | 3,500 | $1.6 | 45,300 | Form 4 |
| 2026-07-24 | Oric Pharmaceuticals, Inc. | S | 7,000 | $12.02 | 38,300 | Form 4 |
| 2026-07-24 | Oric Pharmaceuticals, Inc. | S | 6,100 | $12.02 | 206,672 | Form 4 |
| 2026-07-06 | Oric Pharmaceuticals, Inc. | S | 300 | $12 | 212,772 | Form 4 |
Questions
What stock did Heyman Richard A. buy or sell?
Heyman Richard A. reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($161K), across 1 company.
Is Heyman Richard A. the same person as other filers with this name?
This page covers SEC CIK 1584759 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/heyman-richard-a-1584759.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.